Activity of ceftaroline and epidemiologic trends in Staphylococcus aureus isolates collected from 43 medical centers in the United States in 2009.
about
High prevalence of Panton-Valentine leukocidin among methicillin-sensitive Staphylococcus aureus colonization isolates in rural IowaIn vivo efficacy of ceftaroline fosamil in a methicillin-resistant panton-valentine leukocidin-producing Staphylococcus aureus rabbit pneumonia model.Universal glove and gown use and acquisition of antibiotic-resistant bacteria in the ICU: a randomized trialVaccination against Staphylococcus aureus pneumoniaSelective pharmacologic inhibition of a PASTA kinase increases Listeria monocytogenes susceptibility to β-lactam antibioticsCultures of diabetic foot ulcers without clinical signs of infection do not predict outcomes.Pre-Use Susceptibility to Ceftaroline in Clinical Staphylococcus aureus Isolates from Germany: Is There a Non-Susceptible Pool to be Selected?Detection of Staphylococcus aureus isolates with heterogeneous intermediate-level resistance to vancomycin in the United States.Characterization of nasal and blood culture isolates of methicillin-resistant Staphylococcus aureus from patients in United States Hospitals.Reduced In Vitro Activity of Ceftaroline by Etest among Clonal Complex 239 Methicillin-Resistant Staphylococcus aureus Clinical Strains from AustraliaAssociation between microbial characteristics and poor outcomes among patients with methicillin-resistant Staphylococcus aureus pneumonia: a retrospective cohort study.Current concepts in laboratory testing to guide antimicrobial therapyChlorhexidine and mupirocin susceptibilities of methicillin-resistant staphylococcus aureus from colonized nursing home residents.Detection and Prevalence of Penicillin-Susceptible Staphylococcus aureus in the United States in 2013Single- and multiple-dose study to determine the safety, tolerability, and pharmacokinetics of ceftaroline fosamil in combination with avibactam in healthy subjectsComparing pulsed-field gel electrophoresis with multilocus sequence typing, spa typing, staphylococcal cassette chromosome mec (SCCmec) typing, and PCR for panton-valentine leukocidin, arcA, and opp3 in methicillin-resistant Staphylococcus aureus isCeftaroline fosamil and treatment of acute bacterial skin and skin structure infections: CAPTURE study experience.Activities of vancomycin, ceftaroline, and mupirocin against Staphylococcus aureus isolates collected in a 2011 national surveillance study in the United States.Concordance of nasal and diabetic foot ulcer staphylococcal colonization.Critical appraisal of ceftaroline in the management of community-acquired bacterial pneumonia and skin infections.Ceftaroline fosamil for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infection.Ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections.Inhibitors targeting on cell wall biosynthesis pathway of MRSA.Ceftaroline fosamil: a new cephalosporin active against resistant Gram-positive organisms including MRSA.Ceftaroline fosamil: a review of its use in the treatment of complicated skin and soft tissue infections and community-acquired pneumonia.Ceftaroline Fosamil for the Treatment of Staphylococcus aureus Bacteremia Secondary to Acute Bacterial Skin and Skin Structure Infections or Community-Acquired Bacterial Pneumonia.The times they are a-changin': new antibacterials for skin and skin structure infections.Population PK Modeling and Target Attainment Simulations to Support Dosing of Ceftaroline Fosamil in Pediatric Patients With Acute Bacterial Skin and Skin Structure Infections and Community-Acquired Bacterial Pneumonia.The complex relationship between CD4 count, HIV viral load, trimethoprim-sulfamethoxazole prophylaxis, and skin-and-soft-tissue infection risk in patients with HIV: insights from a causal diagram and simulation study.Trimethoprim-sulfamethoxazole versus vancomycin for severe infections caused by meticillin resistant Staphylococcus aureus: randomised controlled trial.Trimethoprim/sulfamethoxazole versus vancomycin in the treatment of healthcare/ventilator-associated MRSA pneumonia: a case-control study.Molecular characterization of MRSA isolates bracketing the current EUCAST ceftaroline-susceptible breakpoint for Staphylococcus aureus: the role of PBP2a in the activity of ceftaroline.Ceftaroline is active against heteroresistant methicillin-resistant Staphylococcus aureus clinical strains despite associated mutational mechanisms and intermediate levels of resistance.Conventional and Molecular Methods for the Detection of Methicillin-Resistant Staphylococcus aureus.Contemporary use of ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia: CAPTURE study experience.Continued Emergence of USA300 Methicillin-Resistant Staphylococcus aureus in the United States: Results from a Nationwide Surveillance Study
P2860
Q23921454-B3BC328F-5809-4221-BDBC-421028537A7BQ33622755-CB108779-D10C-45E2-93D5-15596BEA6991Q33632050-C9E7E8A1-ACD9-4923-BAD9-FEE4783DB8A9Q33684334-4121219A-1465-40C2-8066-C93432C7C95DQ34058063-7B345B31-3C17-44FC-8D72-366D456759CBQ34219393-1E9AF500-3377-4993-BC86-9D140F2D756CQ35587135-C2720440-A47F-47AD-B8FA-D0996E010BBCQ35598902-2A1F69F2-6FBB-4952-BF75-F46F7FD770C1Q35806363-C16B1BBA-FDFC-4275-B8BD-DFECC92C6D68Q36290502-327B7E96-0D41-46E5-92C1-379370B07591Q36367474-1C290DC1-3C78-4D86-8AAF-4CC7B8ADE945Q36395704-AB67FC29-930E-4CEC-8232-926D0FEFA8A6Q36505471-0AD1CDF9-F5AC-41D3-8A79-D2CEC035128AQ36620792-40114F07-A4A4-4488-814B-0A5EC0034474Q36667104-0E38217D-E682-4884-84FB-C2E32C7C4830Q36667616-105C39F2-C36B-4FE6-9AA9-4D05C7DD6AF9Q37426237-C22325B9-1EAC-475E-BD1E-325DF194CC4FQ37544625-42E87E97-717C-4C8A-A1DB-4DDCB9CE8956Q37707014-EA6942C1-C7E7-417D-ADED-2EEA3D95F006Q38006689-FBE6EF73-AFA7-43FE-97ED-80426BB0C60AQ38010783-DF80149B-B645-4F75-9517-05ECF7AF8540Q38025132-A7A4DBBC-0738-4CFB-AEDC-B2FC57808315Q38035171-E63C2824-9871-4BA7-A00A-60173E72654FQ38061168-AC64B0BD-8529-42A3-B810-321FDBAC0009Q38117077-6282FED0-A2B9-4570-B64A-DCF2659D5E93Q38312543-1B7821E8-4361-41DB-99F2-FAF92F49974EQ38438503-993AE90A-AF45-4146-A415-446925776CBFQ39502727-CEF06BFB-F12D-417D-AB8E-65D8C5E336B2Q39796901-12EA25FF-D2DA-477E-8D7B-50DED04A601BQ40155946-006DED8A-8304-4A05-B89F-ACCA319FF431Q40401599-739D5BE4-708F-43F8-9467-212753DB479DQ40867434-02DB37D8-4707-49FF-9E84-5E5CC40FD394Q42206236-881FE4EC-E86F-4316-A2E0-78D0FD294B90Q46114388-DC2B8BCB-2B7C-400D-8222-968F9F689268Q54292686-023AF4BE-A321-4840-9409-5DA67B594E35Q56934821-DD5B22FC-165E-41FD-A433-7B9BDB0A18B5
P2860
Activity of ceftaroline and epidemiologic trends in Staphylococcus aureus isolates collected from 43 medical centers in the United States in 2009.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Activity of ceftaroline and ep ...... in the United States in 2009.
@ast
Activity of ceftaroline and ep ...... in the United States in 2009.
@en
type
label
Activity of ceftaroline and ep ...... in the United States in 2009.
@ast
Activity of ceftaroline and ep ...... in the United States in 2009.
@en
prefLabel
Activity of ceftaroline and ep ...... in the United States in 2009.
@ast
Activity of ceftaroline and ep ...... in the United States in 2009.
@en
P2093
P2860
P356
P1476
Activity of ceftaroline and ep ...... in the United States in 2009.
@en
P2093
Andrew J Costello
Cassie L Dohrn
Donald Biek
Fathollah Riahi
Ian A Critchley
Jennifer S Kroeger
Kristopher P Heilmann
Sandra S Richter
P2860
P304
P356
10.1128/AAC.00315-11
P407
P577
2011-06-27T00:00:00Z